Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,186.00
Bid: 12,182.00
Ask: 12,188.00
Change: 16.00 (0.13%)
Spread: 6.00 (0.049%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: European markets make gains in early trade

Wed, 21st Dec 2022 09:00

(Alliance News) - Stock prices in London opened higher on Wednesday, while official statistics showed a surge in UK government borrowing, as Westminster forks out billions for its energy support scheme.

The FTSE 100 index of London large-cap stocks opened up 10.67 points, 0.1%, at 7,381.29. Mid-caps were faring better. The FTSE 250 was up 106.72 points, 0.6%, at 18,651.48. The AIM All-Share was up 2.13 points, 0.3%, at 823.87.

The Cboe UK 100 was up 0.2% at 738.20, the Cboe UK 250 was up 0.7% at 16,127.21, and the Cboe Small Companies was up 0.2% at 12,836.20.

UK public sector borrowing ballooned in November, according to Office for National Statistics, due the government's energy support schemes and high inflation.

Public sector net borrowing excluding public sector banks jumped to GBP22.0 billion, which was GBP13.9 billion higher than November of 2021. Borrowing reached its highest level for November since monthly records began in 1993, ONS said.

In European equities early Wednesday, the CAC 40 in Paris and DAX 40 in Frankfurt both were up 0.4%.

Consumer confidence in Germany is expected to improve for the third month in a row in January. The latest GfK forecast is minus 37.8 points for its consumer sentiment index, which is up 2.3 points from the revised figure of minus 40.1 points in December. Economic and income expectations have improved, as has the propensity to buy.

"The consumer sentiment is thus continuing its cautious recovery. More moderate energy prices than originally expected and the German government's relief packages to curb energy costs are responsible for the decreased pessimism," GfK explained.

Wall Street ended higher on Tuesday, with the Dow Jones Industrial Average up 0.3%, the S&P 500 up 0.1% and the Nasdaq Composite marginally higher.

In Asia on Wednesday, the Nikkei 225 index in Tokyo closed down 0.7%, extending Tuesday's losses after the shock move from the Bank of Japan to widen the range for 10-year government bond yields.

Against the yen, the dollar was quoted at JPY131.75 early Wednesday, up versus JPY131.27 at the London equities close on Tuesday.

The dollar was lower elsewhere. Sterling was quoted at USD1.2156, higher than USD1.2139. The euro traded at USD1.0633, edging up from USD1.0627.

In China, equity markets were mixed. The Shanghai Composite lost 0.2%, while the Hang Seng index in Hong Kong added 0.3%. The S&P/ASX 200 in Sydney closed up 1.3%.

Back in London, Bunzl shed 0.8% in early trade.

Bunzl said it expects to deliver strong growth in 2022, with revenue set to grow 17% year-on-year, or by 10% at constant currency.

This is due to "inflation driving underlying revenue growth and the impact of acquisitions further supplementing growth", the distribution services firm said. Bunzl said its operating margin is expected to be slightly ahead of prior guidance, and will be in line with 2021.

Looking ahead to 2023, Bunzl expects revenue to grow slightly, with adjusted operating profit to be "resilient". Adjusted earnings per share are expected to be "moderately" lower from 2022, however.

AstraZeneca edged up 0.1%, after reporting new approvals for Lynparza and Imfinzi in the EU.

Lynparza, or olaparib, has been approved as a combination treatment for the treatment of metastatic castration-resistant prostate cancer. Imfinzi, or durvalumab, has been approved as a first-line treatment in combination with chemotherapy for unresectable or metastatic biliary tract cancer.

Housebuilders were higher in early trade. Persimmon was up 1.4%. Barratt and Taylor Wimpey both were up 1.2%.

"The UK housing market shut down early for Christmas due to uncertainty and the spike in mortgage rates, but house prices have held up well. We expect mortgage rates to fall to around 4.5%, which should mean better activity in spring 2023," Liberum noted.

In the FTSE 250, Pets at Home added 1.4%.

The pet-focused retailer said it has appointed former Asda CEO Roger Burnley to its board. He will join as a non-executive director from February 14.

"Roger has deep knowledge of the retail sector and food supply chains and his experience will be of great value to Pets at Home as it embarks on the next stage of its ambitious strategic plan," said Chair Ian Burke.

Ferrexpo was up 0.1%, as it is said it is now receiving sufficient power levels to bring one pelletiser line back into operation in Ukraine.

"This will allow the group, together with its stockpiled material, to meet the requirements of existing customer contracts," it explained.

The iron pellet producer had suspended its operations in central Ukraine back in October. Ferrexpo said it has produced around 300,000 tonnes of pellets in the fourth quarter so far, and expected total pellet production for 2022 to be around 5.9 to 6.0 million tonnes. In 2021, it produced 11.2 million tones.

On AIM, Scotgold Resources shed 14%.

In the year ended June 30, the Scottish gold producer revenue rose to AUD17.9 million from AUD299,807 a year before. However, its pretax loss widened substantially to AUD10.8 million from AUD5.0 million.

It also lowered its production forecasts for the quarter to December at its Cononish gold and silver mine. Due to changes in the short-term mining schedule and worse-than-expected weather conditions in December, it now expects 2,000 ounces of gold. This is down from a previous range of 3,000 to 3,5000 ounces.

Gold was quoted at USD1,815.76 an ounce early Wednesday, up from USD1,814.62 on Tuesday, while Brent oil fetched at USD79.60 a barrel, little changed from USD79.88.

Still to come on Wednesday's economic calendar, there is a consumer confidence survey from the US at 1500 GMT.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.